|Articles|November 6, 2020
Assessing Multiple Critical Quality Attributes of Monoclonal Antibody and Comparability Assessments
Author(s)Agilent Technologies, Inc.
Discover how LC–MS peptide mapping can be used to characterize and quantify different monoclonal antibody (mAb) critical quality attributes (CQAs).
Newsletter
Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.
Trending on LCGC International
1
Advancing Personalized Medicine with Affinity-Based Separations
2
Easy encapsulation efficiency determination of mRNA in LNPs
3
GC–MS Analysis of Time-Dependent Flavor Development in Marinade Systems
4
Best of the Week: Audible Sound Waves, Cannabis Aroma, HTC Innovation Award
5
